HilleVax Is Exploring the Potential for Continued Development of Its Norovirus Vaccine Candidates in Adults as Well as Business Development Related Activities and Other Strategic Alternatives >HLVX
HilleVax Is Exploring the Potential for Continued Development of Its Norovirus Vaccine Candidates in Adults as Well as Business Development Related Activities and Other Strategic Alternatives >HLVX
HilleVax正在探索其诺如病毒成人疫苗候选品继续发展的潜力，以及与业务发展相关的活动和其他战略选择。>HLVX
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间